• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® ACUSEAL VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number ECH060040
Device Problems Complete Blockage (1094); Peeled/Delaminated (1454)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 07/08/2021
Event Type  Injury  
Event Description
On (b)(6) 2020, a gore® acuseal vascular graft was implanted in the left forearm as a loop shunt for arteriovenous access for hemodialysis.On (b)(6) 2021, the graft occluded.A thrombectomy was performed to resolve the occlusion.On (b)(6) 2021, the graft occluded again.The physicians performed a thrombectomy to resolve the occlusion.During the procedure they suspected delamination of the graft.On (b)(6) 2021, duplex ultrasound was performed, and the radiologist confirmed delamination of the graft.Reportedly the graft was further used as a dialysis access.Reportedly there was a peculiar circumstance, where the shunt suddenly closed "unannounced" during dialysis.It was reported that the physicians therefore decided to implant a new gore® acuseal vascular graft on (b)(6) 2021, as a loop graft bypassing the occluded graft implanted previously.During the intervention they removed a small part of the previously implanted graft.The remaining graft remains implanted.They inspected the explanted graft and found delamination of the graft.
 
Manufacturer Narrative
(b)(4).Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
H6-codes b14 and c19: a review of the manufacturing records indicated the lots met all pre-release specifications.
 
Event Description
The patient presented with hypertension, copd, diabetes, peripheral vein disease and renal disease.On (b)(6) 2020, a gore® acuseal vascular graft was implanted in the left forearm as a loop shunt for arteriovenous access for hemodialysis.On (b)(6) 2021, the graft occluded.The physicians performed a thrombectomy to resolve the occlusion.During the procedure they suspected delamination of the graft.On (b)(6) 2021, duplex ultrasound was performed, and the radiologist confirmed delamination of the graft.Reportedly the graft was further used as a dialysis access.Reportedly there was a peculiar circumstance, where the shunt suddenly closed "unannounced" during dialysis.It was reported that the physician therefore decided to implant a new gore® acuseal vascular graft on (b)(6) 2021, as a loop graft bypassing the occluded graft implanted previously.During the intervention they removed a small part of the previously implanted graft.The rest of the graft remains implanted.It was reported to gore, that they inspected the explanted graft and found delamination of the graft.
 
Manufacturer Narrative
Cause investigation and conclusion: a review of the manufacturing records indicated the lots met all pre-release specifications.The device remains implanted in the patient.Therefore a device evaluation could not be performed.During an additional surgery (reported with gore ref number (b)(4), it 2063970 / 2021171) a small section of the graft has been explanted.Reportedly the explanted section of the graft was discarded at the facility.Therefore an explant evaluation could not be performed.Dicom images have been requested but, as reported to gore, the requested images are not available.Therefore, an imaging evaluation could not be performed.A sketch of the hemodynamics, pictures of the explanted part of the graft, and two screenshot of duplex ultrasound images were provided to gore for evaluation.An engineering evaluation was performed based on these pictures.The evaluation summary states the following: the identity of the reported device is consistent with the device described in the case.The case description could not be confirmed, as no sufficient images of the device were provided for evaluation.The reported failure mode reflects the case description but could not be confirmed.The evaluation found no anomalies attributable to the manufacture of the device.The sketch of the hemodynamics is not complete enough to aid the investigation.The information written down on that sketch list a mix of velocities and volumetric flow rates at what appears to be different locations along the graft that cannot be confirmed and doesn¿t add value the evaluation.Based on the event description and the subsequent investigation we are unable to determine the cause of this incident and assign a root cause.In the instructions for use the following possible complications are stated: v.Possible complications with the use of any vascular prosthesis a.Complications which may occur in conjunction with the use of any vascular prosthesis include but are not limited to: thrombosis; mechanical disruption of the graft.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® ACUSEAL VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
sibylle staerk
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14850054
MDR Text Key294903277
Report Number2017233-2022-03060
Device Sequence Number1
Product Code DSY
Combination Product (y/n)Y
Reporter Country CodeNL
PMA/PMN Number
K130215
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/17/2023
Device Catalogue NumberECH060040
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/26/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age59 YR
Patient SexFemale
-
-